LEADER 00980nam0-22002891--450- 001 990008320450403321 005 20111229133346.0 035 $a000832045 035 $aFED01000832045 035 $a(Aleph)000832045FED01 035 $a000832045 100 $a20060505d1910----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $ay-------001yy 200 1 $aAtti della Commissione per la statistica giudiziaria e notarile$erelazioni e verbali delle discussioni della sessione del dicembre 1909$fMinistero di Grazia e Giustizia e dei Culti 210 $aRoma$cStamperia reale$d1910 215 $a382 p.$d25 cm. 676 $a353.409 450 21$v21$zita 710 01$aItalia.$bMinistero di grazia e giustizia e dei culti$0227424 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990008320450403321 952 $aXVI F 54$b768$fFGBC 959 $aFGBC 996 $aAtti della Commissione per la statistica giudiziaria e notarile$9744759 997 $aUNINA LEADER 00933nam0-2200313---450 001 990009295530403321 005 20171027104056.0 035 $a000929553 035 $aFED01000929553 035 $a(Aleph)000929553FED01 035 $a000929553 100 $a20101210d1968----km-y0itay50------ba 101 0 $aita 102 $aIT 105 $aa-------001yy 200 1 $a<>circolazione assistita e il cuore artificiale$fR. Fumero, F. M. Montevecchi, U. F. Tesler 210 $aMilano$cRecordati$d1968 215 $aIX, 280 p.$cill.$d25 cm 225 1 $aCollana di monografie cardiologiche$v21 610 0 $aCuore artificiale 676 $a617.4120592 700 1$aFumero,$bRoberto$027082 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990009295530403321 952 $a90 CCH CUORE 25$b658$fFMEBC 959 $aFMEBC 996 $aCircolazione assistita e il cuore artificiale$9770093 997 $aUNINA LEADER 02369nam 2200337 450 001 9910598196003321 005 20230324163859.0 035 $a(CKB)4100000011302183 035 $a(NjHacI)994100000011302183 035 $a(EXLCZ)994100000011302183 100 $a20230324d2020 uy 0 101 0 $aeng 135 $aur||||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aFunctional Polymers for Controlled Drug Release /$fUmile Gianfranco Spizzirri 210 1$aBasel :$cMDPI - Multidisciplinary Digital Publishing Institute,$d2020. 215 $a1 online resource (204 pages) 311 $a3-03928-490-8 330 $aThis Special Issue focuses on the synthesis and characterization of hydrogels specifically used as carriers of biological molecules for pharmaceutical and biomedical employments. Pharmaceutical applications of hydrophilic materials has emerged as one of the most significant trends in the area of nanotechnology. To propose some of the latest findings in this field, each contribution involves an in-depth analysis including different starting materials and their physico-chemical and biological properties with the aim of synthetizing high-performing devices for specific use. In this context, intelligent polymeric devices able to be morphologically modified in response to an internal or external stimulus, such as pH or temperature, have been actively pursued. In general, hydrophilic polymeric materials lead to high in vitro and/or in vivo therapeutic efficacy, with programmed site-specific feature showing remarkable potential for targeted therapy. This Special Issue serves to highlight and capture the contemporary progress in this field. Relevant resources and people to approach - American Association Pharmaceutical Scientists (AAPS): web: www.aaps.org; email: (marketing division): Marketing@aaps.org; (mmeting division): Meetings@aaps.org - International Association for Pharmaceutical Technology (APV): web: apv-mainz.de; email (managing director). 606 $aPharmacology 615 0$aPharmacology. 676 $a615.1 700 $aSpizzirri$b Umile Gianfranco$01280433 801 0$bNjHacI 801 1$bNjHacl 906 $aBOOK 912 $a9910598196003321 996 $aFunctional Polymers for Controlled Drug Release$93084992 997 $aUNINA